JPRN-UMIN000009631招募中未知
Efficacy and safety of a selective neutrophil elastase inhibitor in surgery for patients with Crohn's disease: A randomized controlled study - Efficacy and safety of a selective neutrophil elastase inhibitor in surgery for patients with Crohn's disease
Department of Surgery 2,Tokyo Women's Medical University0 个研究点目标入组 20 人开始时间: 2012年12月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Medical history of hypersensitivity to sivelestat Age below 16 years old at the time of obtaining consent Judgment of ineligibility to be a subject by the principle investigator
研究者
相似试验
已完成
不适用
A clinical study of the usefulness of a neutrophil elastase inhibitor in patients with postoperative acute exacerbation of interstitial pneumonia complicated with lung cancerInterstitial pneumonia combine with lung cancerJPRN-UMIN000008862Department of Thoracic Surgery Juntendo University School of Medicine120
尚未招募
1 期
Functional evaluation of neutrophil of patients at high risk for infection treated with monocyte/ neutrophil apheresisJPRN-UMIN000012245Mie University Hospital40
尚未招募
1 期
Functional evaluation of neutrophil of patients at high risk for infection treated with multiple monocyte/ neutrophil aphaeresesulcerative colitis, large bowel perforation, esophageal cancer, colorectal cancerJPRN-UMIN000013269Mie University Graduate School of Medicine10
招募中
不适用
to diagnose the kidney injury in early stages by a biomarkerCTRI/2014/09/004971Indian Council of Medical Research400
进行中（未招募）
1 期
Evaluation of efficacy and bioavailability of ibuprofen lysinatePain on an inflammatory basis (otitis and otomastoiditis, adenite, cellulite, arthritis) and post-operative painMedDRA version: 21.0Level: PTClassification code 10050533Term: Pain assessmentSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.1Level: LLTClassification code 10063374Term: Pain scaleSystem Organ Class: 10022891 - InvestigationsEUCTR2019-000647-27-ITDicofarm S.p.A.84